Researchers uncover mechanisms of common inherited mental retardation

Jan 08, 2008
Researchers uncover mechanisms of common inherited mental retardation
Dr. Kimberly Huber investigated how Fragile X syndrome affects communication between cells in the hippocampus, a region of the brain that is involved in learning and memory. Fragile X syndrome is the most common cause of inherited mental retardation and the most common genetic cause of autism. Credit: UT Southwestern Medical Center

Researchers at UT Southwestern Medical Center are uncovering how brain cells are affected in Fragile X syndrome, the most common cause of inherited mental retardation and the most common genetic cause of autism.

“I think we’ve discovered a core mechanism underlying Fragile X syndrome,” said Dr. Kimberly Huber, assistant professor of neuroscience and senior author of a study appearing in Wednesday’s edition of the Journal of Neuroscience.

Dr. Huber’s research with mice focuses on how Fragile X syndrome affects communication between cells in the hippocampus, a region of the brain that is involved in learning and memory. Her findings show that two different chemical signals go awry in Fragile X syndrome, indicating that drugs that interact with these signals might be a pathway to help treat the syndrome.

“The more we know about how signaling mechanisms in the brain lead to normal memory and learning, the better we can understand what goes wrong in conditions such as Fragile X syndrome,” said Dr. Huber, who is a Southwestern Medical Foundation Scholar in Medical Research. “Our research is laying the groundwork for such understanding and indicates a new area for research.”

Fragile X syndrome got its name because it affects a single gene, Fmr1, on the X chromosome. Under a microscope, the area around the gene looks narrower than normal, or “fragile.” According to the Centers for Disease Control and Prevention, the syndrome, which mostly occurs in males, affects about one in every 4,000 white males in the U.S.

It often causes a distinct physical appearance including an elongated face with protruding ears, hyperflexible joints, and mental deficits ranging from mood disorders to severe mental retardation. Much of the current treatment focuses on behavioral therapy combined with medications to control mood and seizures.

Dr. Huber previously co-discovered that mice genetically engineered to lack Fmr1 have a defective signaling system in the brain that controls learning in the hippocampus. This system relies on a chemical messenger called glutamate, which under normal circumstances causes nerve cells to make proteins and change their electrical firing patterns in response to learning situations. Without a properly working Fmr1 gene, the glutamate signaling system malfunctions.

In 2007 she and colleagues at UT Southwestern found that acetylcholine, another specific signaling chemical, affects the same protein-making factory that glutamate does. This research appeared in the Oct. 24, 2007, issue of the Journal of Neuroscience.

“We suggest that treatment that affects the acetylcholine system might be a supplement or alternative to drugs targeting the glutamate pathway,” Dr. Huber said.

In the current study, she and postdoctoral researcher Dr. Jennifer Ronesi investigated a protein, called Homer, which serves as a kind of structural support for the glutamate system. The Homer–glutamate support system is disconnected in Fragile X syndrome. Dr. Huber’s group discovered that this disconnection results in an inability of brain cells to make the new proteins important for learning and memory.

Source: UT Southwestern Medical Center

Explore further: Growing a blood vessel in a week

add to favorites email to friend print save as pdf

Related Stories

World remembers Chernobyl, haunted by nuclear fears

Apr 25, 2011

The world on Tuesday marks a quarter century since the world's worst nuclear disaster at Chernobyl in Ukraine, haunted by fears over the safety of atomic energy after the Japan earthquake.

Osteoblasts are bone idle without Frizzled-9

Mar 14, 2011

New research shows that the Wnt receptor Frizzled-9 (Fzd9) promotes bone formation, providing a potential new target for the treatment of osteoporosis. The study appears online on March 14 in The Journal of ...

Recommended for you

Growing a blood vessel in a week

Oct 24, 2014

The technology for creating new tissues from stem cells has taken a giant leap forward. Three tablespoons of blood are all that is needed to grow a brand new blood vessel in just seven days. This is shown ...

Testing time for stem cells

Oct 24, 2014

DefiniGEN is one of the first commercial opportunities to arise from Cambridge's expertise in stem cell research. Here, we look at some of the fundamental research that enables it to supply liver and pancreatic ...

Team finds key signaling pathway in cause of preeclampsia

Oct 23, 2014

A team of researchers led by a Wayne State University School of Medicine associate professor of obstetrics and gynecology has published findings that provide novel insight into the cause of preeclampsia, the leading cause ...

Rapid test to diagnose severe sepsis

Oct 23, 2014

A new test, developed by University of British Columbia researchers, could help physicians predict within an hour if a patient will develop severe sepsis so they can begin treatment immediately.

User comments : 0